Farmacología en la tercera edad: Medicamentos de uso continuo y peligros de la interacción medicamentosa


Autoria(s): Haddad, Marcela Filié; Takamiya, Aline Satie; da Silva, Eulália Maria Martins; Barbosa, Débora de Barros
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

19/10/2009

Resumo

Introduction: It was observed a considerable growth of elderly people. They are who use more medicines. The physiological changes associated with the age advancing can make pharmacokinetic and pharmacodynamic alterations. The cognitive decline, physical limitations and associate chronic pathology affect the medications appropriately use ability. Aims: Based in a literature review, appoint the main pharmacological groups prescribed to the elderly and the drug-drug interaction risks. Conclusion: The most of elderly use continually at least 3 medicines, the most prescribed are to cardiovascular and psychic diseases treatment.

Formato

22-27

Identificador

http://dx.doi.org/10.4321/S1134-928X2009000100004

Gerokomos, v. 20, n. 1, p. 22-27, 2009.

1134-928X

http://hdl.handle.net/11449/71199

10.4321/S1134-928X2009000100004

S1134-928X2009000100004

2-s2.0-70349976092

2-s2.0-70349976092.pdf

Idioma(s)

spa

Relação

Gerokomos

Direitos

openAccess

Palavras-Chave #Continuous use medicines #Drug-drug interaction #Elderly #acetylsalicylic acid #amitriptyline #analgesic agent #antacid agent #antihypertensive agent #antiinflammatory agent #antiulcer agent #anxiolytic agent #beta adrenergic receptor blocking agent #bromazepam #calcium channel blocking agent #chlordiazepoxide #chlorpropamide #clomipramine #diazepam #diclofenac #diltiazem #dipeptidyl carboxypeptidase inhibitor #diuretic agent #flurazepam #furosemide #heparin #methyldopa #mineral #neuroleptic agent #nifedipine #nitrazepam #phenylbutazone #unindexed drug #vitamin #aged #aging #cardiovascular disease #drug safety #drug use #elderly care #human #mental disease #pharmacodynamics #prescription #risk assessment #social psychology #unspecified side effect
Tipo

info:eu-repo/semantics/article